STOCK TITAN

Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Bio-Rad Laboratories, Inc. (NYSE: BIO) will report its first quarter 2024 financial results on May 7, 2024. The conference call will take place at 2 PM Pacific Time. Investors can access the call through dial-in or a live webcast.
Bio-Rad Laboratories, Inc. (NYSE: BIO) comunicherà i risultati finanziari del primo trimestre del 2024 il 7 maggio 2024. La conferenza telefonica si terrà alle 14:00, ora del Pacifico. Gli investitori potranno partecipare alla chiamata tramite accesso telefonico o tramite una trasmissione web dal vivo.
Bio-Rad Laboratories, Inc. (NYSE: BIO) reportará los resultados financieros del primer trimestre de 2024 el 7 de mayo de 2024. La llamada de conferencia se realizará a las 2 PM hora del Pacífico. Los inversores podrán acceder a la llamada mediante marcación telefónica o a través de una transmisión en vivo por internet.
바이오-래드 연구소(Bio-Rad Laboratories, Inc., NYSE: BIO)는 2024년 5월 7일에 2024년도 1분기 재무 결과를 보고할 예정입니다. 컨퍼런스 콜은 태평양 표준시로 오후 2시에 진행됩니다. 투자자들은 전화 접속 또는 생중계 웹캐스트를 통해 참여할 수 있습니다.
Bio-Rad Laboratories, Inc. (NYSE: BIO) publiera ses résultats financiers pour le premier trimestre de 2024 le 7 mai 2024. La conférence téléphonique aura lieu à 14h00, heure du Pacifique. Les investisseurs peuvent accéder à l'appel par composition téléphonique ou par une webdiffusion en direct.
Bio-Rad Laboratories, Inc. (NYSE: BIO) wird am 7. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 bekannt geben. Die Telefonkonferenz findet um 14 Uhr Pazifischer Zeit statt. Investoren können den Anruf über eine Einwahl oder einen Live-Webcast verfolgen.
Positive
  • None.
Negative
  • None.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To participate, dial 800-274-8461 within the U.S. or (+1) 203-518-9814 outside the U.S., access code: BIORAD. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad Laboratories report its first quarter 2024 financial results?

Bio-Rad Laboratories will report its first quarter 2024 financial results on May 7, 2024.

What is the ticker symbol for Bio-Rad Laboratories?

The ticker symbol for Bio-Rad Laboratories is BIO.

How can investors access the conference call discussing the financial results?

Investors can access the conference call by dialing 800-274-8461 within the U.S. or (+1) 203-518-9814 outside the U.S. with the access code BIORAD. A live webcast will also be available on the company's website.

Where can investors find a replay of the webcast?

A replay of the webcast will be available in the 'Investor Relations' section of the company's website under 'Events & Presentations' at investors.bio-rad.com for up to a year.

Bio-Rad Laboratories, Inc.

NYSE:BIO

BIO Rankings

BIO Latest News

BIO Stock Data

7.97B
19.96M
15.24%
81.7%
1.98%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
HERCULES

About BIO

bio-rad laboratories (nyse: bio and biob) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. founded in 1952, bio-rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. throughout its existence, bio-rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. based in hercules, ca, bio-rad has operations worldwide.